AMBROSIA BIO has developed a disruptive, evolutionary enzyme technology platform that is used to design superior enzymes to convert obesity-promoting industrial sugars into minimal-calorie rare sugars. AMBROSIA BIO’s B2B business model will provide the leading sugar & juice manufacturers the opportunity to meet customer expectations of sugar reduction without affecting the consumption experience. AMBROSIA BIO will deliver tailored (Plug and Play) engineering solutions for its partners to meet surging Allulose demand.

Ambrosia Bio

Org chart

Teams

Offices